JPRN-UMIN000003807Completed未知
A study for comparison of triple combination therapy (bucillamine, salazosulphapiridine and methotrexate) with TNF-blocking biologics and methotrexate combination therapy concerning efficacy and tolerability for rheumatoid arthritis - JaSTAR Study
Japan Association of Rheumatologists in Private Practice0 sites160 target enrollmentStarted: July 1, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 160
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(Complication) Patients who had any of the following diagnoses or medical history: 1) Autoimmune disease except for Sjogren syndorome, and malignancy 2) Drug allergy 3) Severe heart, lung, liver. kidney and hematolodical disorders (Treatment) 4)Patient who recived intramuscular, intoravenous or epidural injection of corticosteroids within 4 weeks prior to the entry or during study 5)Patient who recived intraarticular corticosteroid at dose of over 20mg/month of prednisolone, and patients who recieved intraarticular corticosteroid at any dose within 4weeks prior to study entry or the day for observation of first end point 6)Patient who recived systemic corticosteroid with a dose of >10mg of predonisolone within 4 weeks prior to the study or during the study and Patients whose corticosteroid dose were changed within 4 weeks prior to the day for observation of first end point 7)Patient who received NSAIDs with an overdosage within 4 weeks prior to the study entry or during the study (Surgery) 8)Patient who had surgery judged to have an influence on this study by doctor 9)Patient who had the following treatment or procedure: plasma exchange, leukocyte depleted therapy or arthrocentesis against affected joint. except for the arthrocenesis following intraarticular injection of corticosteroid, within 4 weeks prior to the study entry or during the study (Others) 10)Patient who is in pregnancy, lactating, or with a possibility of the pregnancy and woman who hopes for pregnancy during study or within 1 month after the end of this study, and man who wishes his partner be pregnant during the study or within 3 months after the end of this study 11)Patient who can not go to a hospital for check-up on an appointed day 12)Patient who participated other clinical trial program within 4 months prior to the study entry (including post-marketing clinical study) 13)When principal investigator or sub investigators of this study judge the patients disqualified as a subject of this study
Investigators
Similar Trials
Completed
Not Applicable
Treatment of Swallowing disorders in stroke patientsDysphagia.Difficulty in swallowingIRCT201202218629N1Tehran University of Medical Sciences15
Recruiting
Phase 3
Evaluation of the effect of interferon beta-1b in the treatment of COVID-19IRCT20200921048786N1Dezfoul University of Medical Sciences82
Not yet recruiting
Not Applicable
Comparison of three different combinations of ketofol for induction of general anaesthesiaCTRI/2021/07/034673Bijaya Chingtham
Completed
Not Applicable
sefulness of visual analog scale for efficacy of medicines for asthma: Comparison between ICS/LABA/LAMA triple and ICS/LABA combination therapy - a retrospective cohort studyasthmaJPRN-UMIN000045636Kurume University School of Medicine308
Not yet recruiting
Phase 3
Comparison of the effectiveness of topical minoxidl and cetirizine in androgenetic alopeciaIRCT20230308057655N1Esfahan University of Medical Sciences62